We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleAbametapir 0.74% (Xeglyze) for the Treatment of Head Lice.AuthorsSunder, MeeraAbstractAbametapir 0.74% (Xeglyze) is a topical ovicidal pediculicide labeled for the treatment of head lice infestation in patients six months and older.1,2.PublicationAmerican Family Physician, 2022, Vol 106, Issue 1, p91ISSN0002-838XPublication typeAcademic Journal